Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 13.551.571.551.401.55

What is the latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS is 13.55 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202513.55
Mar20241.57
Mar20231.55
Mar20221.40
Mar20211.55

How is EV/Core EBITDA of EMCURE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 13.55
763.06
Mar2024 1.57
1.29
Mar2023 1.55
10.71
Mar2022 1.4
-9.68
Mar2021 1.55 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹32,619.9 Cr 1.3% 3.4% 30.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,145.0 Cr -0.1% -2.5% 6.5% Stock Analytics
DIVIS LABORATORIES ₹172,989.0 Cr -0.2% -2.8% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,322.0 Cr 2.3% 1.2% 41.1% Stock Analytics
CIPLA ₹112,149.0 Cr 0.7% 1.9% -4.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,483.0 Cr 0.1% -2.4% 2.3% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

1.3%

3.4%

30.4%

SENSEX

-1%

-5.7%

-9.7%


You may also like the below Video Courses